These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38923314)

  • 41. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.
    Castilla J; Navascués A; Fernández-Alonso M; Reina G; Albéniz E; Pozo F; Álvarez N; Martínez-Baz I; Guevara M; García-Cenoz M; Irisarri F; Casado I; Ezpeleta C;
    Euro Surveill; 2016 Jun; 20(22):. PubMed ID: 27277013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
    Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK
    Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.
    Davlin SL; Blanton L; Kniss K; Mustaquim D; Smith S; Kramer N; Cohen J; Cummings CN; Garg S; Flannery B; Fry AM; Grohskopf LA; Bresee J; Wallis T; Sessions W; Garten R; Xu X; Elal AI; Gubareva L; Barnes J; Wentworth DE; Burns E; Katz J; Jernigan D; Brammer L
    MMWR Morb Mortal Wkly Rep; 2016 Jun; 65(22):567-75. PubMed ID: 27281364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.
    Flannery B; Zimmerman RK; Gubareva LV; Garten RJ; Chung JR; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Ohmit SE; Belongia EA; McLean HQ; Gaglani M; Piedra PA; Mishin VP; Chesnokov AP; Spencer S; Thaker SN; Barnes JR; Foust A; Sessions W; Xu X; Katz J; Fry AM
    J Infect Dis; 2016 Oct; 214(7):1010-9. PubMed ID: 27190176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19.
    Pebody RG; Whitaker H; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Thompson C; Galiano M; Lackenby A; Robertson C; O'Doherty MG; Owens K; Yonova I; Shepherd SJ; Moore C; Johnston J; Donati M; McMenamin J; Lusignan S; Zambon M
    Vaccine; 2020 Jan; 38(3):489-497. PubMed ID: 31685296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    Hu W; DeMarcus LS; Sjoberg PA; Robbins AS
    PLoS One; 2021; 16(8):e0256165. PubMed ID: 34450617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
    Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
    Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
    Whitaker H; Findlay B; Zitha J; Goudie R; Hassell K; Evans J; Kalapotharakou P; Agrawal U; Kele B; Hamilton M; Moore C; Byford R; Stowe J; Robertson C; Couzens A; Jamie G; Hoschler K; Pheasant K; Button E; Quinot C; Jones T; Anand S; Watson C; Andrews N; de Lusignan S; Zambon M; Williams C; Cottrell S; Marsh K; McMenamin J; Lopez Bernal J
    Influenza Other Respir Viruses; 2024 May; 18(5):e13284. PubMed ID: 38773753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
    Gaglani M; Pruszynski J; Murthy K; Clipper L; Robertson A; Reis M; Chung JR; Piedra PA; Avadhanula V; Nowalk MP; Zimmerman RK; Jackson ML; Jackson LA; Petrie JG; Ohmit SE; Monto AS; McLean HQ; Belongia EA; Fry AM; Flannery B
    J Infect Dis; 2016 May; 213(10):1546-56. PubMed ID: 26743842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada.
    Andrew MK; Shinde V; Hatchette T; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney J; McGeer A; Nichols MK; Powis J; Richardson D; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    BMC Infect Dis; 2017 Dec; 17(1):805. PubMed ID: 29284435
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
    Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
    Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16.
    Castilla J; Martínez-Baz I; Navascués A; Casado I; Aguinaga A; Díaz-González J; Delfrade J; Guevara M; Ezpeleta C; ;
    Euro Surveill; 2018 Jan; 23(2):. PubMed ID: 29338809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014/15 season, Japan.
    Sugaya N; Shinjoh M; Kawakami C; Yamaguchi Y; Yoshida M; Baba H; Ishikawa M; Kono M; Sekiguchi S; Kimiya T; Mitamura K; Fujino M; Komiyama O; Yoshida N; Tsunematsu K; Narabayashi A; Nakata Y; Sato A; Taguchi N; Fujita H; Toki M; Myokai M; Ookawara I; Takahashi T
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Price AM; Flannery B; Talbot HK; Grijalva CG; Wernli KJ; Phillips CH; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Mutnal M; Geffel KM; Nowalk MP; Tartof SY; Florea A; McLean C; Kim SS; Patel MM; Chung JR
    Clin Infect Dis; 2023 Apr; 76(8):1358-1363. PubMed ID: 36504336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
    Wang Y; Zhang T; Chen L; Greene C; Ding Y; Cheng Y; Yang C; Zeng S; Hua J; Zhou S; Song Y; Luan L; Zhang J; Zhao G
    Vaccine; 2016 May; 34(21):2460-2465. PubMed ID: 27016650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).
    Skowronski DM; Sabaiduc S; Leir S; Rose C; Zou M; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Bastien N; Li Y; Jassem A; Krajden M; De Serres G
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine.
    Appiah GD; Blanton L; D'Mello T; Kniss K; Smith S; Mustaquim D; Steffens C; Dhara R; Cohen J; Chaves SS; Bresee J; Wallis T; Xu X; Abd Elal AI; Gubareva L; Wentworth DE; Katz J; Jernigan D; Brammer L;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(21):583-90. PubMed ID: 26042650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.
    Remschmidt C; Rieck T; Bödeker B; Wichmann O
    BMC Infect Dis; 2015 Mar; 15():137. PubMed ID: 25887460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.